242 related articles for article (PubMed ID: 26046533)
1. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
Li Y; Abdourahman A; Tamm JA; Pehrson AL; Sánchez C; Gulinello M
Pharmacol Biochem Behav; 2015 Aug; 135():70-82. PubMed ID: 26046533
[TBL] [Abstract][Full Text] [Related]
2. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
[TBL] [Abstract][Full Text] [Related]
3. Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Li Y; Sanchez C; Gulinello M
Int J Neuropsychopharmacol; 2017 Jun; 20(6):510-515. PubMed ID: 28158336
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity.
Kugathasan P; Waller J; Westrich L; Abdourahman A; Tamm JA; Pehrson AL; Dale E; Gulinello M; Sanchez C; Li Y
J Psychopharmacol; 2017 Mar; 31(3):365-376. PubMed ID: 27678087
[TBL] [Abstract][Full Text] [Related]
5. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
[TBL] [Abstract][Full Text] [Related]
7. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
[TBL] [Abstract][Full Text] [Related]
8. Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents.
Waller JA; Nygaard SH; Li Y; du Jardin KG; Tamm JA; Abdourahman A; Elfving B; Pehrson AL; Sánchez C; Wernersson R
BMC Neurosci; 2017 Aug; 18(1):56. PubMed ID: 28778148
[TBL] [Abstract][Full Text] [Related]
9. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
[TBL] [Abstract][Full Text] [Related]
10. Chronic vortioxetine treatment in rodents modulates gene expression of neurodevelopmental and plasticity markers.
Waller JA; Tamm JA; Abdourahman A; Pehrson AL; Li Y; Cajina M; Sánchez C
Eur Neuropsychopharmacol; 2017 Feb; 27(2):192-203. PubMed ID: 28108062
[TBL] [Abstract][Full Text] [Related]
11. The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression.
Bhagya V; Srikumar BN; Raju TR; Shankaranarayana Rao BS
J Neurosci Res; 2015 Jan; 93(1):104-20. PubMed ID: 25146499
[TBL] [Abstract][Full Text] [Related]
12. Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus.
Chen F; du Jardin KG; Waller JA; Sanchez C; Nyengaard JR; Wegener G
Eur Neuropsychopharmacol; 2016 Feb; 26(2):234-245. PubMed ID: 26711685
[TBL] [Abstract][Full Text] [Related]
13. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
Sanchez C; Asin KE; Artigas F
Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
[TBL] [Abstract][Full Text] [Related]
14. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.
Dziwota E; Olajossy M
Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095
[TBL] [Abstract][Full Text] [Related]
15. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
Waller JA; Chen F; Sánchez C
Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
17. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior.
Eskelund A; Li Y; Budac DP; Müller HK; Gulinello M; Sanchez C; Wegener G
J Neurochem; 2017 Jul; 142(1):118-131. PubMed ID: 28407315
[TBL] [Abstract][Full Text] [Related]
18. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice.
Pytka K; Gawlik K; Pawlica-Gosiewska D; Witalis J; Waszkielewicz A
Metab Brain Dis; 2017 Apr; 32(2):547-556. PubMed ID: 27888375
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
Li Y; Raaby KF; Sánchez C; Gulinello M
Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
[TBL] [Abstract][Full Text] [Related]
20. A Critical Role of Mitochondria in BDNF-Associated Synaptic Plasticity After One-Week Vortioxetine Treatment.
Chen F; Danladi J; Ardalan M; Elfving B; Müller HK; Wegener G; Sanchez C; Nyengaard JR
Int J Neuropsychopharmacol; 2018 Jun; 21(6):603-615. PubMed ID: 29514282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
